Hologic $1.65 billion acquisition of Cynosure

Overview:

• Medical products manufacturer Hologic has acquired medical aesthetics company Cynosure in a $1.65 billion deal.
• The price tag came to $66 per Cynosure outstanding share.
• The deal closely follows a similar acquisition of a medical aesthetics company by Allergan.
• Morgan Stanley acted as financial adviser for Hologic and Leerink Partners acted for Cynosure.
• The transaction is expected to close in March or April of 2017.

Kurt Stumpo - Journalist